Language Selection



<<Return to Laboratory

Requisition Forms

Reference Details


Sera analyzed for the detection and quantitation of IgG antibodies against B. abortus, B. suis and B. melitensis by the agglutination of whole cells.

Test Category:
Brucella spp.
Illnesses and Diseases:
  • Brucellosis

Serum sample. Minimum volume required – 1.0 mL. Hyperlipemic, hemolysed or contaminated sera may yield erroneous results.

Collection Method:

Collect blood in serum separator tubes.

Specimen Processing, Storage and Shipping:

Transfer an aliquot of serum to a 1.5 mL screw-top vial with O-ring (Sarstedt vial). Store specimens refrigerated or frozen until shipped for testing.  Ship frozen on dry ice or on wet ice. 

Transportation of Dangerous Goods:

Shipping of specimens shall be done by a TDG certified individual in accordance with TDG regulations. For additional information regarding classification of specimens for the purposes of shipping, consult either Part 2 Appendix 3 of the TDG Regulations or section 3.6.2 of the IATA Dangerous Goods Regulations as applicable.


Patient Criteria:

Appropriate clinical symptoms and suspected exposure to Brucella spp.  

Accompanying Documentation:

Please list all clinical symptoms appropriate to the suspected area of infection detailed by submission of a completed Bioforensics Assay Development and Diagnostics requisition form including sender name, address and telephone number, patient name or identifier (referring lab #), date of birth, suspected exposure, test(s) requested, type of specimen and date collected.  Append all relevant clinical background information and testing performed. Please include patient travel history if applicable.



Specimens may be subject to rejection if they are not the appropriate sample type, have insufficient volume or are not accompanied by relevant patient information.



Methods and Interpretation of Results:

Brucella microagglutination test (BMAT) used for the detection and quantification of total antibodies and IgG antibodies against B. abortus, B. suis and B. melitensis in microtiter wells by the agglutination of whole cells.

If a single serum sample produces a titre ≥1:160 that declines at least 4 fold with reduction by 2-Mercaptoethanol (2-ME), this is reported as presumptive evidence of acute brucellosis. If paired acute and convalescent phase serum specimens, drawn at least 14 days apart, demonstrate a 4-fold increase in titre, this is considered presumptive evidence of acute brucellosis.

This assay is only for the smooth Brucella variants, it does not measure antibodies to B. canis or other rough variants.


Turnaround Time:

30 calendar days.  Please note that during times when large numbers of samples are received or if tests must be repeated, the turnaround time may be longer.

Phone #: (204) 784-5928 or 1-877-212-6108
Fax: (204) 789-5009
  1. Brown SL et al. 1981. Safranin O-stained antigen microagglutination test for detection of Brucella antibodies. J. Clin. Microbiol. 13:398-400.
  2. Gaultney JB et al. 1971. Microagglutination procedures for febrile agglutination tests. Appl. Microbiol. 22:635-640.
Related Information: